Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MorningBio is a South Korean research-driven animal health and nutrition company specializing in high-quality feed additives. Founded in 2004, the company utilizes its proprietary Joint Matrix-coating Technology (JMT) to manufacture protected solutions such as coated organic acids, omega-3 fatty acids, vitamins, amino acids, and slow-release minerals. These products, including MATONIN, MAT C, and PROCID, are designed to bypass the rumen, improve gut health, alleviate heat stress, and maximize productivity in swine, poultry, and ruminants. MorningBio actively exports its products globally, including to the United States, and maintains international quality certifications such as FAMI-QS.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morningbio.